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In rabbit kidney (RK13) cells, gG-negative BHV-1 exhibited significant defects in plaque formation and growth compared to
that of gG-positive BHV-1. RK13 cells infected with gG-negative BHV-1 exhibited a distinctive CPE and contained a larger
number of cells stained with trypan blue dye compared to those infected with gG-positive strains, suggesting that
gG-negative BHV-1 inflicted more damage to the infected cells than gG-positive BHV-1. Apoptotic cell death was induced in
RK13 cells infected with gG-negative BHV-1 within 8 h. In contrast, the onset of apoptosis in gG-positive BHV-1-infected RK13
cells was around 12–16 h postinfection. In the presence of caspase inhibitor Z-Asp-CH2-DCB, multiplication of gG-negative
minus BHV-1 was significantly increased. These results demonstrate that BHV-1 gG is involved in stabilizing the cell
structure, postponing apoptotic process, and efficient BHV-1 replication in infected RK13 cells. © 2001 Academic Press
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Bovine herpesvirus 1 (BHV-1), a member of the Alpha-
herpesvirinae subfamily, is distributed worldwide and is
an economically important pathogen of cattle (Yates,
1982). Alphaherpesviruses, including BHV-1, share a
number of homologous glycoproteins that are involved in
various steps of the viral replicative cycle, such as virus
attachment, penetration, and cell-to-cell infection. To
date, it has been reported that BHV-1 expresses at least
10 glycoproteins, designated as glycoprotein B (gB), gC,
gD (reviewed in Tikoo et al., 1995), gE, gG, gI (reviewed
in Baranowski et al., 1996), gH, gL (Van Drunen Littel-van
den Hurk et al., 1996), gK (Khadr et al., 1996), and gM (Wu
et al., 1998).
BHV-1 gG is encoded by the open reading frame (ORF)
4 within the short unique (US) region of the viral genome
Keil et al., 1996). Homologous genes of BHV-1 US ORF4
ere previously identified in the majority of alphaherpes-
iruses (McGeoch et al., 1985, 1987; Rea et al., 1985;
rabb et al., 1992; Telford et al., 1992; Eberle et al., 1993;
Kongsuwan et al., 1993; Spatz et al., 1994; Ficorilli et al.,
1995; Slomka et al., 1995; Engelhardt and Keil, 1996;
Fukushi et al., 1997). Despite this high conservation, the
precise role of the homologous gG proteins in the alpha-
herpesviruses is not well understood. In contrast to other
herpesvirus glycoproteins, gG is unusual in that it is
secreted into the medium of the infected cells. Although
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488they have not been seen in herpes simplex virus type 1
(HSV-1), secreted forms of gG were previously shown for
HSV-2 (McGeoch et al., 1987), pseudorabies virus (PrV)
(Rea et al., 1985), equine herpesvirus 4 (EHV-4) (Crabb et
al., 1992), BHV-1 (Keil et al., 1996), BHV-5 (Engelhardt and
Keil, 1996), and infectious laryngotracheitis virus (ILTV)
(Kongsuwan et al., 1993). For several alphaherpesviruses
such as HSV-1, PrV, and BHV-1, gG was shown to be
nonessential for viral replication in cultured cells (Balan
et al., 1994; Mettenleiter, 1994; reviewed in Baranowski,
1996; Otsuka and Xuan, 1996). Recently, it was reported
that the gG protein of HSV-1 is required for efficient
infection through the apical membranes of polarized
cells (Tran et al., 2000).
In our previous study, we showed that the knockout of
BHV-1 gG does not affect viral attachment, penetration,
and one-step growth in Madin–Darby bovine kidney
(MDBK) cells and that BHV-1 gG appears to be involved
in the cell-to-cell transmission mechanism of BHV-1 (Na-
kamichi et al., 2000). In this study, we analyzed the
growth behavior of gG-negative BHV-1 recombinant in
rabbit kidney (RK13) cells and observed unique charac-
teristics of gG-negative BHV-1 mutant that were not pre-
viously noticed in MDBK cells.
RESULTS
Western blot analysis of BHV-1 mutants
In most cases, previous analyses of the growth char-
acteristics of BHV-1 mutants with an inactivation for spe-
cific gene product focused on infections only in MDBK
cells because of narrow host cell range. We observed
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489BHV-1 gG INVOLVEMENT IN APOPTOSIS PREVENTIONthat the gG-negative BHV-1 grew poorly in MDBK cells by
multistep replication, whereas the one-step growth of
BHV-1 was not affected by the lack of gG. We concluded
that gG functioned as an important mediator of the cell-
to-cell transmission of BHV-1 (Nakamichi et al., 2000). We
tested the growth performance of BHV-1 in several cell
types other than MDBK cells. Of these, RK13 cells al-
lowed productive multiplication of BHV-1 equally as well
as MDBK cells, and thus we set out to analyze the
replication of a gG insertion–deletion mutant of BHV-1 in
RK13 cells.
BHV-1/TF9-5 is a gG-negative BHV-1 recombinant in
which BHV-1 US ORF4 was inactivated by the insertion–
deletion of thymidine kinase (TK) gene of PrV (Otsuka
and Xuan, 1996) and BHV-1/TF9-5R is a gG-repaired
mutant of BHV-1/TF9-5 (Nakamichi et al., 2000). To con-
firm the deletion and repair of BHV-1 gG protein in these
recombinants, mouse antiserum was raised to Esche-
richia coli (E. coli)-expressed BHV-1 US ORF4 protein,
nd Western blot analysis was performed using this
ntiserum. MDBK cells were infected with BHV-1 [10
laque-forming units (PFU)/cell], and cells and superna-
ants were harvested at 24 h postinfection (p.i.).
As described under Materials and Methods, proteins
rom cell lysates (Fig. 1A) and supernatants (Fig. 1B)
ere subjected to sodium dodecyl sulfate (SDS)–poly-
crylamide gel electrophoresis (SDS–PAGE) and West-
rn blotting. For gG-positive BHV-1/TF2-1 and BHV-1/
F9-5R viruses, intracellular forms of BHV-1 gG protein
FIG. 1. Western blot analysis of BHV-1 gG. MDBK cells were infected
with BHV-1/TF2-1 (control strain, lane 1), BHV-1/TF9-5 (gG-negative
strain, lane 2), or BHV-1/TF9-5R (gG-repaired strain, lane 3). At 24 h p.i.,
proteins from cell lysates (A) and culture supernatants (B) were sepa-
rated by SDS–PAGE and subjected to Western blotting using anti-BHV-1
gG antiserum. Arrows and bracket on the right indicate the location of
gG proteins mentioned in the main text, and molecular mass standards
(kDa) are shown on the left.ith an apparent molecular mass of 70 kDa were de-
ected in the cell lysates (Fig. 1A, lanes 1 and 3, closedrrow). In the supernatants, secreted forms of gG with an
pparent molecular mass of 65 kDa (Fig. 1B, lanes 1 and
, open arrow) and high-molecular-mass proteins, which
igrated as a diffuse band (Fig. 1B, lanes 1 and 3,
racket), were detected for BHV-1/TF2-1 and BHV-1/TF9-
R. The intracellular and secreted forms of BHV-1 gG
ere identified previously by using rabbit antiserum
gainst vaccinia virus-expressed BHV-1 gG, named anti-
acgG serum (Keil et al., 1996).
The reactivity of mouse antiserum generated here was
very similar to that of anti-VacgG serum. In BHV-1/TF9-5, the
ORF of the gG gene was interrupted by the insertion of the
PrV TK gene at the XhoI–XhoI site (Otsuka and Xuan, 1996).
This was expected to produce a truncated amino-terminal
polypeptide of gG. However, the antiserum did not recog-
nize any of the proteins in BHV-1/TF9-5 (Figs. 1A and 1B,
lane 2). Similarly, no BHV-1 gG was detected in cell lysate
and supernatant of RK13 cells infected with BHV-1/TF9-5
(data not shown). At this time, we do not know whether the
truncated gG was produced but not recognized by the
antiserum or whether the gG transcript became unstable as
a result of the insertion of the PRV TK gene, and no trun-
cated gG polypeptide was produced.
Reduction in plaque size of gG-negative BHV-1
We compared the plaque formation of gG-negative
BHV-1 mutant, BHV-1/TF9-5, with that of other gG-posi-
tive BHV-1 recombinants. Since the gG locus of BHV-1/
TF9-5 was inactivated by the insertion of the PrV TK
gene, a BHV-1/TF2-1 strain, which carries the PrV TK
gene at the BHV-1 TK site, was used as a control strain.
Figure 2 shows the plaque morphologies of BHV-1 re-
combinants on RK13 cells at 2 days after infection, and
Fig. 3 shows the relative size of the plaques obtained
through image analysis. On RK13 cells, the plaque size of
BHV-1/TF9-5 was reduced to 15% of that of the control
strain BHV-1/TF2-1. However, the plaque size of gG-
repaired mutant, BHV-1/T9-5R, was comparable to that of
the control strain. It is of interest to note that in RK13 cells
the plaque size of BHV-1/TF9-5 was smaller than that of
the BHV-1/TF9-3 strain lacking gE, which plays a prom-
inent role in plaque formation and cell-to-cell infection.
We reported earlier that in MDBK cells gE minus BHV-1/
TF9-3 produced much smaller plaques than did gG-
negative BHV-1/TF9-5 (Nakamichi et al., 2000). These
data indicate that BHV-1 gG plays a crucial role for
plaque formation in the infection of the RK13 cell mono-
layer by BHV-1.
Defective viral growth of gG-negative BHV-1
To assay the overall growth performance of BHV-1/TF9-5
and other gG-positive viruses, one-step growth curves in
RK13 cells were compared. Cells were infected with BHV-1
recombinants at a multiplicity of infection (m.o.i.) of 10. At
different time points p.i., cells and supernatants were har-
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As shown in Fig. 4, BHV-1/TF2-1 and BHV-1/TF9-5R showed
steep increases in viral titers between 12 and 24 h p.i.,
reaching a near-plateau level at 24 h p.i. In contrast, BHV-
1/TF9-5 grew very poorly; at 24 h p.i., virus titer was about
10% of that of the control strains. The titer of BHV-1/TF9-5
gadually increased up to 48 h p.i., but it was significantly
lower than that of gG-positive strains, suggesting that
BHV-1 gG is required for efficient virus growth by single-
step multiplication in RK13 cells.
Penetration and plaque-formation efficiency
of gG-negative BHV-1 in RK13 cells
FIG. 2. Morphologies of plaques formed by BHV-1 recombinants on
RK13 cell monolayer. RK13 cells were infected with BHV-1/TF2-1,
HV-1/TF9-5, or BHV-1/TF9-5 R. After a 48-h incubation at 37°C, cells
ere fixed, stained with crystal violet, and photographed. Original
agnification, 1003.Penetration kinetics and plaque-formation efficiency of
BHV-1/TF9-5 in RK13 cells were compared with those ofcontrol strains, as described under Materials and Meth-
ods. As shown in Fig. 5A, BHV-1/TF9-5 and the other
control strains showed essentially the same penetration
kinetics, suggesting that the lack of gG did not cause a
significant reduction in BHV-1 penetration into RK13
cells. Figure 5B shows the plaque-formation efficiency of
BHV-1/TF9-5 and other gG-positive viruses on RK13 cells.
Each BHV-1 recombinant, the stock of which was pre-
pared by propagation in MDBK cells, was titrated on both
MDBK and RK13 cells, and the ratio of plaque numbers
was calculated. On RK13 cells, plaques formed by BHV-
FIG. 3. Plaque size of BHV-1 recombinants on RK13 cells. RK13 cell
monolayers were infected with BHV-1/TF2-1, BHV-1/TF9-3 (gE-negative
strain), BHV-1/TF9-5, or BHV-1/TF9-5R, and incubated for 48 h at 37°C.
Cells were fixed and stained with crystal violet; the digital images of
more than 100 plaques (/BHV-1 strain) were prepared; and the plaque
area was calculated. The average area of plaques formed by BHV-1/
TF2-1 was defined as 100%, and vertical lines indicate standard errors.
FIG. 4. One-step growth kinetics of BHV-1 recombinants in RK13
cells. RK13 cell monolayers were infected with BHV-1/TF2-1 (M), BHV-
1/TF9-5 (F), or BHV-1/TF9-5R (E) at an m.o.i. of 10 for 1 h at 37°C.
Extracellular viruses were inactivated by low-pH treatment, and the
infected cells were washed and overlaid with culture medium. Imme-
diately thereafter (0 h) and at time points indicated, progeny viruses
were titrated on MDBK cells. Mean values and standard deviations
from the results of three independent experiments are shown.
491BHV-1 gG INVOLVEMENT IN APOPTOSIS PREVENTION1/TF2-1 and BHV-1/TF9-5R were reduced by about 70%
compared to those on MDBK cells. The efficiency of
plaque formation of gG-negative BHV-1/TF9-5 was
slightly lower than that of BHV-1/TF2-1, although a sig-
nificant difference was not observed. These results indi-
cated that gG-negative BHV-1 was able to penetrate and
form plaques in RK13 cells, although the size was small.
Therefore, the impaired growth of gG-negative BHV-1 in
RK13 cells does not result from a defect in attachment to
or penetration into cells.
Cytopathic effect (CPE) of gG-negative BHV-1 in
infected cells
In the experiments analyzing the one-step replication
FIG. 5. Penetration kinetics and plaque-formation efficiency of BHV-1
recombinants in RK13 cells. (A) Penetration kinetics of BHV-1 recom-
binants into RK13 cells. The penetration rates of BHV-1/TF2-1 (M),
BHV-1/TF9-5 (F), and BHV-1/TF9-5R (E) were determined by low-pH
inactivation of extracellular virus as described under Materials and
Methods. The percentage of the plaque number at each time point was
calculated in comparison with those of the PBS-treated control. Mean
values are averages of three independent experiments and vertical
lines indicate standard deviations. (B) Plaque-formation efficiency of
gG-negative BHV-1 on RK13 cells. BHV-1 recombinants were plaque-
titrated on MDBK and RK13 cells, and the percentages of the plaque
numbers on RK13 cells were calculated with reference to those on
MDBK cells. Mean values are averages of three independent experi-
ments and vertical lines show standard deviations.of BHV-1, we noticed a unique CPE on the RK13 cell
monolayer infected with gG-negative BHV-1. RK13 cellsgrown on glass coverslips were mock-infected or were
infected with either BHV-1/TF2-1 or BHV-1/TF9-5 at an
m.o.i. of 10, and CPE was monitored by differential inter-
ference contrast microscopy (Fig. 6). When RK13 cells
were infected with the control BHV-1/TF2-1 strain, the
infected cells appeared smooth and rounded, and they
tended to detach from the surface of the coverslips
earlier, between 16 and 20 h p.i. In contrast, the BHV-1/
TF9-5-infected cells appeared irregularly shaped, and
they remained attached to the substrate at 20 h p.i.,
whereas most of the BHV-1/TF2-1-infected cells de-
tached from the plates. To examine this phenomenon
more quantitatively, the percentage of cells attached to
FIG. 6. Morphological changes of RK13 cells during the course of
infection. RK13 cells grown on glass coverslips were infected with
BHV-1/TF2-1 or BHV-1/TF9-5 at an m.o.i. of 10, and overlaid with culture
medium. At 4, 8, 12, 16, and 20 h p.i., the infected cells were observed
by differential interference contrast microscopy and photographed.
Representative areas of each culture are shown. Images of mock-
infected cells are shown at 4 and 20 h p.i. only. Original magnification,
2003.
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492 NAKAMICHI ET AL.the plate was counted, as described under Materials and
Methods, after infecting RK13 monolayers with BHV-1/
TF9-5 or various gG-positive BHV-1 strains. As shown in
Fig. 7, RK 13 cells infected with BHV-1/TF9-5 attached to
the plate 24 h after infection, while over 90% of RK13 cells
infected with all other gG-positive BHV-1 strains de-
tached from the plates.
To examine the degree of cell damage caused by
gG-negative BHV-1 infection, the infected cells were
stained with trypan blue, and the percentage of cells
excluding the trypan blue dye was monitored. As shown
in Fig. 8, after infecting cells with gG-positive BHV-1, the
percentage of cells capable of excluding trypan blue
decreased gradually between 12 and 72 h p.i., and at
72 h p.i. approximately 30–50% of the infected cells lost
their capability of excluding the dye. In contrast, BHV-1/
TF9-5-infected cells lost their dye-exclusion capability
steeply and linearly between 24 and 72 h p.i., and about
90% of the infected cells were not able to exclude trypan
blue dye.
In the trypan blue staining test viable cells exclude the
dye, although not all the cells that exclude the dye are
viable. In the infection of MDBK cells by wild-type BHV-1,
a significant portion of BHV-1-infected cells was also
resistant to trypan blue staining, even at the later time
points after infection (Devireddy and Jones, 1999), and
FIG. 7. Adhesion of RK13 cells to culture plates in the infection with
BHV-1 recombinants. RK13 cells were mock-infected or infected with
wild-type BHV-1 (LA) strain, BHV-1/TF7-4 (gC-negative strain), BHV-1/
TF9-1L1 (US3 protein-negative strain), BHV-1/TF9-3, BHV-1/TF9-5, BHV-
/TF9-5R, and BHV-1/TF9-7 (gI-negative strain) at an m.o.i. of 10 for 1 h,
ashed,and overlaid with culture medium. At the different times indi-
ated, cells floating in the medium or attached to the plate were
ounted by using a hemocytometer. The percentages of cells remain-
ng attached to the substrate were calculated with reference to the total
ell number. Mean values and standard deviations from the results of
hree independent experiments are shown.our data essentially agree with their results. BHV-1 in-
fection induces the change in adherence to the substra-tum and membrane permeability in RK13 cells. It would
appear that gG affects membrane permeability and at-
tachment to substratum in BHV-1-infected RK13 cells.
The function of gG in these phenomena remains to be
elucidated.
Apoptosis in cells infected with gG-negative BHV-1
BHV-1 induces apoptotic cell death in different cell
types in different ways (Hanon et al., 1996, 1998; De-
vireddy and Jones, 1999). The major characteristic fea-
tures of cells undergoing apoptosis are cleavage of
genomic DNA into oligonucleosomal DNA fragments
(Arends et al., 1990; Wyllie, 1980) and condensation of
he chromatin (Martin et al., 1994; Duvall and Wyllie,
986). To test whether apoptosis is associated with the
nique CPE of BHV-1/TF9-5, we first monitored the frag-
entation of genomic DNA in RK13 cells infected with
HV-1 recombinants (Fig. 9). RK13 cell monolayers were
nfected with BHV-1 recombinants at an m.o.i. of 10, and
t different times after infection, low-molecular-weight
NA was extracted, separated on a 1.5% agarose gel,
nd stained, as described under Materials and Methods.
t 4 h p.i., fragmentation of DNAs derived from mock-
nfected and BHV-1-infected cells was not observed (Fig.
, lanes 1–5). When RK13 cells were infected with gG-
ositive BHV-1 strains (Fig. 9, lanes 2, 3, and 5), DNA
addering patterns were observed between 12 and 16 h
.i. In contrast, a clear DNA ladder was detected at 8 h
fter infection by gG-negative BHV-1/TF9-5 virus (Fig. 9,
ane 4). When BHV-1 recombinants were inactivated by
FIG. 8. Measurement of cell viability after BHV-1 infection as judged
by trypan blue staining. RK13 cells were mock-infected or infected with
BHV-1/TF2-1, BHV-1/TF7-4, BHV-1/TF9-1L1, BHV-1/TF9-3, BHV-1/TF9-5,
BHV-1/TF9-5R, and BHV-1/TF9-7, at an m.o.i. of 10 for 1 h, washed, and
overlaid with culture medium. At the different times indicated, cells
were collected by centrifugation and stained with trypan blue dye, and
cell numbers were counted with a hemocytometer. The percentages of
cells excluding trypan blue dye were calculated with reference to the
total cell number. Mean values are averages from triplicate samples
and vertical lines indicate standard deviations.
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493BHV-1 gG INVOLVEMENT IN APOPTOSIS PREVENTIONirradiation with ultraviolet (UV) rays, fragmentation of
genomic DNA was not readily detected at 16 h after
infection.
To confirm the occurrence of apoptosis in BHV-1/
TF9-5-infected cells, the nuclei of RK13 cells were
stained with 49,6-diamidino-2-phenylindole (DAPI) at
8 h p.i., as described under Materials and Methods
(Fig. 10). In the BHV-1/TF9-5-infected cells, some nu-
clei were uniquely condensed and partitioned into
several nodules. No such nuclei were found in cells
infected with the control strain (BHV-1/TF2-1) and gG-
repaired strain (BHV-1/TF9-5R). At 8 h p.i., chromatin
condensation was observed in 8–12% of BHV-1/TF9-5-
FIG. 9. DNA fragmentation of RK13 cells following BHV-1 infection. R
HV-1/TF9-1L1 (lane 3), BHV-1/TF9-5 (lane 4), and BHV-1/TF9-5R (lane
, 12, and 16 h p.i., the low-molecular-weight DNAs were extracted, elec
f DNA patterns from RK13 cells incubated with UV-inactivated BHV-1 r
re shown. Lane M, molecular-weight marker (l DNA digested with H
FIG. 10. Nuclear morphologies of RK13 cells infected with BHV-1
ecombinants. RK13 cells were mock-infected or infected with BHV-1/
F2-1, BHV-1/TF9-5, or BHV-1/TF9-5R at an m.o.i. of 10. At 8 h p.i., cell
uclei were stained with DAPI DNA dye and observed under UV light,
s described under Materials and Methods. Arrows point to nuclei thatt
R
ontain condensed chromatin in the BHV-1/TF9-5-infected cells. Orig-
nal magnification, 4003.infected cells (data not shown). Taken together, these
results indicated that BHV-1 gG prevented apoptotic
cell death, which occurred in the early stages (about
8 h p.i.) of viral replication.
Inhibition of apoptosis enhances replication
of gG-negative BHV-1
To determine whether apoptosis induced at the
early stages of infection is associated with defective
growth of gG-negative BHV-1, the growth performance
of BHV-1/TF9-5 and control strains was measured in
the presence of caspase inhibitor, benzyloxycarbonyl-
Asp-CH2OC(O)-2,6-dichlorobenzene (Z-Asp-CH2-DCB).
Caspases are cysteine proteases, which play a prin-
cipal role in apoptotic cell death (Porter et al., 1997).
Z-Asp-CH2-DCB is a chemically synthesized protease
nhibitor, which preferentially inhibits interleukin-1
b-converting enzyme (ICE) or ICE-like proteases
Mashima et al., 1995) and is used as a broad speci-
icity inhibitor of caspases (Kitanaka et al., 1997; Mess-
er et al., 1999; Edelstein et al., 1999; Oda et al., 1999).
ells were pretreated with culture medium containing
00 mM Z-Asp-CH2-DCB for 2 h and were infected with
HV-1 strains at an m.o.i. of 10. After a 24-h incubation
t 37°C in the presence of 100 mM Z-Asp-CH2-DCB,
total virus yields, cell-free or cell-associated viruses,
were titrated on MDBK cells. Z-Asp-CH2-DCB treat-
ment completely inhibited DNA fragmentation in BHV-
1/TF9-5-infected cells within 8 h p.i. (data not shown).
As shown in Fig. 11A, the viral titers of control strains
in the presence of Z-Asp-CH2-DCB were slightly in-
creased compared to those in untreated or dimethyl-
sulfoxide (DMSO)-treated cultures. In contrast, total
virus yield of BHV-1/TF9-5 was increased by more than
threefold following Z-Asp-CH2-DCB treatment. Figures
1B and 11C show the amount of infectious BHV-1
ecombinant progenies that are cell-associated and
lls were mock-infected (lane 1) or infected with BHV-1/TF2-1 (lane 2),
n m.o.i. of 10 for 1 h, washed, and overlaid with culture medium. At 4,
esed in a 1.5% agarose gel, and stained with ethidium bromide. Images
inants are shown at 16 h p.i. only. Data from one of three experiments
nd EcoRI).K13 ce
5) at a
trophorhat are in culture supernatants, respectively. When
K13 cells were treated with Z-Asp-CH2-DCB, the in-
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494 NAKAMICHI ET AL.fectious titers of cell-associated BHV-1/TF9-5 viruses
were significantly increased and reached the same
level as that of the control strains (Fig. 11B). In con-
trast, the amount of BHV-1/TF9-5 viruses released from
the infected cells was much lower than that of gG-
positive viruses in the presence of Z-Asp-CH2-DCB
Fig. 11C). These data indicate that inhibition of apo-
tosis leads to enhanced multiplication of gG minus
FIG. 11. Replication of BHV-1 recombinants in the presence of Z-Asp-
CH2-DCB. RK13 cell monolayers pretreated with culture medium con-
aining 100 mM Z-Asp-CH2-DCB for 2 h at 37°C were infected with
BHV-1 recombinants at an m.o.i. of 10, and further incubated under
medium containing 100 mM Z-Asp-CH2-DCB. After a 24-h incubation
eriod, total virus yields (A), cell-associated viruses (B), and cell-free
iruses (C) were titrated on MDBK cells, as described under Materials
nd Methods. Virus yields in the presence of normal culture medium
nd medium containing DMSO are also shown as control experiments.
ean values and standard deviations from results of three indepen-
ent experiments are shown.HV-1 in RK13 cells, although virus release is not
ncreased.
a
aDISCUSSION
In RK13 cells we observed that the gG-negative BHV-1
rew poorly, not only in multistep growth (data not
hown), but also in one-step replication. These data
ndicate that BHV-1 gG is not only involved in the cell-to-
ell spread mechanism, but also involved in some other
rocess of viral replication in RK13 cells. The gG-nega-
ive BHV-1 could penetrate into RK13 cells equally as
ell as could the control strains, suggesting that BHV-1
G is not required for viral penetration into RK13 cells,
nd that the knockout of BHV-1 gG does not affect the
unction of other glycoproteins such as gD, gB, and gH,
hich are involved in viral penetration. From these data
nd the report describing that gG of BHV-1 is not a
irion-associated protein (Keil et al., 1996), it is likely that
he defective growth of gG-negative BHV-1 occurs at the
tage after penetration into RK13 cells.
When RK13 cells were infected with BHV-1, the typical
igns of apoptosis such as DNA fragmentation and chro-
atin condensation were detected between 12 and 16 h
.i., whereas they were observed as early as 8 h p.i. in
K13 cells infected with gG-negative BHV-1. From these
esults, it can be concluded that the expression of BHV-1
G delays the apoptotic process in the BHV-1-infected
K13 cells. US ORF4 gene encoding BHV-1 gG is under
he transcriptional control of an early promoter (Keil et al.,
996), and it seems to be reasonable that BHV-1 gG
unctions for prevention of apoptosis at the early stage of
iral replication. The poor growth of gG-negative BHV-1
n RK13 cells in one-step growth seems to be the result
f the early stages of apoptosis in RK13 cells. Indeed, in
he presence of caspase inhibitor Z-Asp-CH2-DCB, the
ield of cell-associated progeny virus was significantly
ncreased. However, the yield of cell-free virus was not
ncreased by inhibiting apoptosis, and it is possible that
HV-1 gG also plays a role in the efficient release of virus
rom infected RK13 cells.
Devireddy and Jones (1999) demonstrated that MDBK
ells undergo apoptosis near the end of BHV-1 infection
about 48 h p.i.). It would appear that RK13 cells are
ighly susceptible to apoptotic cell death induced by
HV-1 infection when compared to the susceptibility of
DBK cells to this phenomenon. We monitored the DNA
ragmentation patterns and condensation of nuclei in
DBK cells infected with gG-negative BHV-1 and other
G-positive strains at different time points, but no signif-
cant difference in the occurrence of apoptosis was ob-
erved (data not shown). Therefore, our previous obser-
ation, that the one-step repication of gG-negative BHV-1
as not impaired in MDBK cells, can be explained by the
ow susceptibility to apoptosis in the gG-negative BHV-1-
nfected MDBK cells. The fact that UV-inactivated BHV-1
ould not induce apoptosis in both MDBK (Devireddy
nd Jones, 1999) and RK13 cells (Fig. 9) suggests that
poptosis induction occurs at the step after viral entry,
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495BHV-1 gG INVOLVEMENT IN APOPTOSIS PREVENTIONsuch as expression of viral proteins, DNA replication,
and egress of virions from the cells. At present, the
mechanism by which BHV-1 induces apoptosis in these
nonlymphoid cells is not well understood.
Since the gG-negative BHV-1 strain BHV-1/TF9-5 was
generated by the insertion–deletion of the PrV TK gene
nto the US ORF4 gene (Otsuka and Xuan; 1996), it is
ossible that a truncated form of BHV-1 gG is produced,
lthough it did not react with our anti-gG antibodies. We
onstructed another BHV-1 gG-negative mutant in which
he promoter sequence and the 59 end of the coding
egion of the gG gene were deleted. Induction of apo-
tosis in RK13 cells infected with this gG-negative mu-
ant was very similar to that observed in RK 13 cells
nfected with BHV-1/TF9-5 (data not shown). Previously,
e constructed another BHV-1 mutant, BHV-1/TF9-1L1, in
hich the US ORF3 gene was inactivated but the gG
gene was intact (Takashima et al., 1999). For HSV, it is
known that mutant viruses lacking the coding sequences
of the homologous US3 gene induce apoptosis in vitro
(Leopardi et al., 1997) and in vivo (Asano et al., 1999),
suggesting that the HSV US3 product prevents apoptosis.
n contrast, BHV-1/TF9-1L1 possessed the same ability
s the wild-type BHV-1, to prevent apoptosis induced by
smotic shock (Takashima et al., 1999), and in this study,
he occurrence of apoptosis in the BHV-1/TF9-1L1-in-
ected RK13 was very similar to that in the control BHV-
-infected RK13 cells (Fig. 9). It would appear that the
omologous US ORF3 gene product of BHV-1 is not
involved in the prevention of apoptosis in MDBK and
RK13 cells.
Recently, Jerome et al. (1999) demonstrated that the
SV-1 US5 gene encoding glycoprotein J (gJ) is required
or prevention of apoptosis induced by anti-Fas antibody
nd UV-irradiation. However, interruption of the US5 (gJ)
gene had no effect on HSV-1 multiplication (Balan et al.,
1994). Our data seem to be significant, in that a herpes-
virus glycoprotein, BHV-1 G, is associated with the pre-
vention of apoptosis and efficient virus replication in
infected cells.
The gG-negative BHV-1 has unique cytopathological
effects on structure and adherence characteristics in
infected RK13 cells that were not seen in gG-positive
BHV-1. Addition of Z-Asp-CH2-DCB did inhibit apoptosis
in RK13 cells infected with gG-negative BHV-1 but did not
alter the unique CPE of gG-negative BHV-1 (data not
shown). In summary, we conclude that gG has two roles
during BHV-1 infection. First, it affects the structure and
adherence of the infected cells and could thus be in-
volved in the cell-to-cell spread mechanism of the virus.
Second, since the infection of RK13 cells with the gG-
negative virus shows signs of apoptosis earlier than that
in wild-type infected cells, gG could be involved in de-
laying the apoptosis process triggered during BHV-1
infection. It may be possible that stabilizing the structureof infected RK13 cells by gG is the cause of the delay of
the apoptosis process.
MATERIALS AND METHODS
Cells and viruses
MDBK and RK13 cells were cultivated in Dulbecco’s
modified Eagle’s medium (DMEM; Nissui, Japan) con-
taining 10% FCS and 100 mg/ml of kanamycin. The BHV-1
ecombinants used in this study were described in pre-
ious reports (Otsuka and Xuan, 1996; Takashima et al.,
999; Nakamichi et al., 2000).
ntiserum
Antiserum specific for BHV-1 gG was raised in mice
noculated with E. coli-expressed protein. The SalI–NruI
ragment within the BHV-1 US ORF4 gene was inserted
into the bacterial expression vector pGEX-5X-3 (Pharma-
cia Biotech, Piscataway, NJ). The resulting plasmid,
pGEX-BUS4-SN, contained the 0.9-kb US ORF4 sequence
fused to the glutathione S-transferase (GST) gene. E. coli
DH5a was transformed with pGEX-BUS4-SN, and ex-
ression of the GST-gG fusion protein was induced with
sopropyl-1-thio-b-D-galactopyranoside according to the
anufacturer’s protocol. Bacterial pellets were resus-
ended in TNE buffer (50 mM Tris–HCl, 50 mM NaCl, 1
M EDTA, pH 8.0) containing lysozyme (1 mg/ml) and 1
M (6)-dithiothreitol (DTT), incubated at 30°C for 1 h
nd subjected to five freeze/thaw cycles (280 to 37°C).
he insoluble fraction was washed with 0.5% Triton X-100
hree times and treated with 8 M urea solution (8 M urea,
0 mM Tris–HCl, 1 mM EDTA, 1 mM DTT) at room
emperature for 1 h, and centrifuged at 7000 g for 30 min.
he supernatant was then subjected to dialysis in TNE
uffer including 1 mM DTT at 4°C and was used to raise
nti-gG antibody. Mice (ICR strain) were inoculated in-
raperitoneally four times with approximately 100 mg fu-
ion protein; the first injection was with Freund’s com-
lete adjuvant followed by three injections at 7-day in-
ervals with antigen emulsified in Freund’s incomplete
djuvant. Sera were collected 1 week after final immu-
ization. Antiserum was used for Western blotting at
ilutions of 1:100.
estern blotting
Western blot analysis was performed according to the
rocedure described previously (Murata et al., 1999).
Briefly, MDBK cells in six-well dishes were infected with
BHV-1 recombinants at an m.o.i. of 10, washed, and
overlaid with 2 ml of Opti-MEM I (Gibco BRL, Gaithers-
burg, MD). After 24-h incubation at 37°C, the infected
cells and the culture supernatant were separated by
centrifugation at 1500 rpm for 5 min. The infected cells
were washed and suspended in 200 ml of PBS, and the
supernatant was concentrated by ultrafiltration using ul-
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496 NAKAMICHI ET AL.trafree-CL filter (10000 NMWL; Millipore, Bedford, MA) to
a final volume of approximately 200 ml, according to the
manufacturer’s recommendation. Proteins in each frac-
tion were separated under reducing conditions in 0.4%
SDS–10% polyacrylamide gels, transferred to polyvinyli-
dene difluoride membranes (Millipore), and reacted with
antiserum. A horseradish peroxidase-linked secondary
conjugate was used, and reactive bands were visualized
with 0.5 mg/ml diaminobenzidine and 0.01% hydrogen
peroxide (Murata et al., 1999).
Plaque assays
Plaque titration was performed according to the stan-
dard procedure described previously (Murata et al.,
1999). Briefly, monolayers of MDBK and RK13 cells were
incubated with BHV-1 inoculum at a 10-fold dilution se-
ries for 1 h at 37°C, washed, and overlaid with culture
medium containing 0.5% methylcellulose (Sigma, St.
Louis, MO). After a 2-day incubation at 37°C, cells were
fixed with ethanol and stained with crystal violet, after
which plaques were counted. The plaque sizes of BHV-1
recombinants on RK13 cells were measured after titra-
tion, as previously described (Nakamichi et al., 2000).
The digital image of each plaque was prepared, and the
percentage of plaque area was calculated with reference
to those of the control strain BHV-1/TF2-1. For virus plat-
ing, each BHV-1 recombinant was titrated on both MDBK
and RK13 cells, and the percentages of the plaque num-
ber on RK13 cells were calculated with reference to
those on MDBK cells.
Growth curves
RK13 cell monolayers grown in six-well culture dishes
were infected with a BHV-1 recombinant at an m.o.i. of
10. After a 1-h absorption period, the cells were washed
with PBS, treated with low-pH solution (40 mM citric acid,
10 mM KCl, 135 mM NaCl) to inactivate extracellular virus
(Van Drunen Littel-van den Hurk et al., 1996), and overlaid
with prewarmed culture medium. At different times p.i.,
cells and supernatant were harvested, and virus progeny
was plaque-titrated on MDBK cells.
Virus penetration assay
Assay of penetration kinetics was performed essen-
tially as described previously (Brack et al., 1999). RK13
cells in 12-well culture dishes were infected with approx-
imately 200 PFU of a BHV-1 recombinant for 20 min at
4°C. The inoculum was then removed, and prewarmed
medium was added to allow penetration. At different
times after the temperature shift, extracellular viruses
were inactivated with low-pH treatment, washed with
PBS, and overlaid with culture medium including meth-
ylcellulose. After a 2-day incubation period at 37°C, cells
were fixed and stained. Plaques were counted, and the
t
ppercentage penetration was calculated with reference to
a PBS-treated control.
Cell count
RK13 cells in 12-well culture plates were mock-in-
fected or infected with BHV-1 recombinants at an m.o.i. of
10 for 1 h, washed, and overlaid with normal culture
medium. At different times p.i., the cells floating in the
culture medium were collected by centrifugation at 1500
g for 5 min. For counting of cells adhering to culture
plates, cells were detached by pipetting and collected by
centrifugation. Mock-infected cells and infected cells (0 h
p.i.) were treated with trypsin solution (0.4% trypsin,
0.05% EDTA in PBS) for 5 min at 37°C, suspended by
pipetting, and collected by centrifugation. Collected cells
were resuspended in PBS and stained with trypan blue
solution at a final concentration of 0.2% (w/v). The num-
ber of cells was counted by using a hemocytometer, and
the percentages of positive cells were calculated with
reference to the mock-infected control.
DNA laddering and DAPI staining of nuclei
DNA fragmentation analysis was performed as de-
scribed previously (Takashima et al., 1999). Briefly, RK13
cells in six-well culture dishes were mock-infected or
infected with BHV-1 recombinants at an m.o.i. of 10 and
collected by centrifugation at different time points. Alter-
natively, cells were incubated with BHV-1 recombinants,
which were treated with UV-irradiation (Devireddy and
Jones, 1999). DNA from each sample was extracted,
dissolved in 30 ml of TE buffer (10 mM Tris–HCl, 1 mM
DTA, pH 8.0), and subjected to electrophoresis on a
.5% agarose gel. The DNA was visualized by ethidium
romide staining and photographed under UV light. For
nalysis of chromatin condensation, the infected cells
ere collected by centrifugation at 1500 g for 3 min,
ir-dried on a glass slide, fixed with 100% methanol for 10
in, and incubated with 0.1 mg/ml of DAPI in PBS for 3
min. Slides were observed by fluorescent microscope
and photographed.
Inhibition of apoptosis
Caspase-1 inhibitor V, Z-Asp-CH2-DCB (BioMol Re-
search Laboratories, Plymouth Meeting, PA), was dis-
solved in DMSO at a concentration of 10 mM and stored
at 220°C as a stock solution. Before infection, confluent
monolayers of RK13 cells were incubated for 2 h at 37°C
in culture medium containing Z-Asp-CH2-DCB at a final
oncentration of 100 mM. Cells were then infected with
BHV-1 recombinants at an m.o.i. of 10 for 1 h, washed
with PBS, and overlaid with medium containing 100 mM
-Asp-CH2-DCB. After a 24-h incubation period at 37°C,
ells and supernatants were subjected to three freeze/haw cycles (280 to 37°C). Alternatively, cells and su-
ernatants were separated by centrifugation at 5000 g
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497BHV-1 gG INVOLVEMENT IN APOPTOSIS PREVENTIONfor 3 min, and supernatants or cells plus an equal volume
of culture medium were subjected to freeze/thaw cycles.
To avoid the effect of residual Z-Asp-CH2-DCB, media
obtained from each fraction were diluted more than
10,000-fold and subjected to plaque titration on MDBK
cells.
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